Twist Bioscience (TWST) EBIAT (2018 - 2025)
Historic EBIAT for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$30.5 million.
- Twist Bioscience's EBIAT rose 345.89% to -$30.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$76.6 million, marking a year-over-year increase of 6117.95%. This contributed to the annual value of -$77.7 million for FY2025, which is 6277.42% up from last year.
- Per Twist Bioscience's latest filing, its EBIAT stood at -$30.5 million for Q4 2025, which was up 345.89% from -$27.2 million recorded in Q3 2025.
- Over the past 5 years, Twist Bioscience's EBIAT peaked at $20.4 million during Q2 2025, and registered a low of -$85.6 million during Q2 2024.
- Moreover, its 5-year median value for EBIAT was -$42.4 million (2022), whereas its average is -$42.9 million.
- Per our database at Business Quant, Twist Bioscience's EBIAT plummeted by 6959.45% in 2021 and then skyrocketed by 12383.18% in 2025.
- Over the past 5 years, Twist Bioscience's EBIAT (Quarter) stood at -$45.6 million in 2021, then rose by 8.21% to -$41.8 million in 2022, then fell by 2.83% to -$43.0 million in 2023, then grew by 26.53% to -$31.6 million in 2024, then increased by 3.46% to -$30.5 million in 2025.
- Its last three reported values are -$30.5 million in Q4 2025, -$27.2 million for Q3 2025, and $20.4 million during Q2 2025.